Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases

Authors

  • Fabiana Madotto Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy
  • Carla Fornari Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy
  • Virginio Chiodini Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy
  • Lorenzo G Mantovani Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy and Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
  • Giuseppe Boriani Institute of Cardiology, University of Bologna, Bologna, Italy
  • Sara Conti Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy
  • Giancarlo Cesana Research Centre on Public Health, Department of Statistics and Quantitative Methods, University of Milano- Bicocca, Monza, Italy

DOI:

https://doi.org/10.12974/2313-0946.2014.01.02.3

Keywords:

Cardiovascular disease, defibrillation, epidemiology, health care cost, health care utilization, retrospective studies

Abstract

Introduction: The high cost of treatment with an implantable cardioverter defibrillator (ICD) requires continuous monitoring of its real effectiveness and appropriateness. The aim of this study was to evaluate epidemiological and economic impacts of ICD therapy in Lombardy, the most populated Italian region. Materials and Methods: We extracted data from DENALI, a data warehouse that organizes healthcare administrative databases concerning about ten million people covered by the Lombardy Health System (LHS). We estimated annual rates of first implant and of first replacement from 2000 to 2008. The cohort of patients who underwent a first ICD implantation between 2005 and 2007 was followed from discharge to December 31, 2008 in order to evaluate mean annual total healthcare cost per-capita, mortality and device replacement. Results: We identified 12,732 first implants and 4,833 replacements performed from 2000 to 2008 and we estimated the annual rates: first ICD implants increased from 55 to 236 (per million person-years), and the first replacement rates increased with a peak in 2005. A first ICD implantation cost €23,934 (standard deviation 4,986) on average and the LHS bore a further mean annual cost of €5,760 (95% confidence interval 5,592-5,931) percapita during follow-up: 17% due to drugs, 12% to outpatient visits and 71% to hospitalizations. Conclusions: The results confirm the increase in ICD utilization in Italy, especially in the Lombardy region, and its high economic burden. Age and comorbidities of ICD recipients should be considered in assessing care since they influence survival outcome. Moreover, this study shows how healthcare administrative databases could be useful to understand the impact of a health intervention in large unselected populations.

References

Camm AJ, Nisam S. European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? Europace 2010; 12: 1063-9. http://dx.doi.org/10.1093/europace/euq282

Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Am Heart J 2002; 144: 397-403. http://dx.doi.org/10.1067/mhj.2002.125496

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37. http://dx.doi.org/10.1056/NEJMoa043399

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83. http://dx.doi.org/10.1056/NEJMoa013474

Lubinski A, Bissinger A, Boersma L, Leenhardt A, Merkely B, Oto A, et al. Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries-data from the European Heart Rhythm Association White Book. Europace 2011; 13: 654-62. http://dx.doi.org/10.1093/europace/eur066

Arribas F, Auricchio A, Wolpert C, Merkely B, Merino JL, Boriani G, et al. The EHRA White Book. Europace 2012; 14: iii1-iii55. http://dx.doi.org/10.1093/europace/eus256

Boriani G, Berti E, Biffi M, Marino M, Sassone B, Villani GQ, et al. Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a "real world" regional registry. Europace 2010; 12: 1224-30. http://dx.doi.org/10.1093/europace/euq176

Boriani G, Biffi M, Martignani C, Diemberger I, Valzania C, Bertini M, et al. Expenditure and value for money: the challenge of implantable cardioverter defibrillators. QJM 2009; 102: 349-56. http://dx.doi.org/10.1093/qjmed/hcp025

Lynd LD, O'Brien BJ. Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence. J Cardiovasc Electrophysiol 2003; 14: S99-S103. http://dx.doi.org/10.1046/j.1540-8167.14.s9.3.x

Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471-80. http://dx.doi.org/10.1056/NEJMsa051989

Gandjour A, Holler A, Dipl Ges O, Adarkwah CC. Costeffectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II). Value Health 2011; 14: 812-7. http://dx.doi.org/10.1016/j.jval.2011.02.1180

Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, et al. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 2009; 11: 716- 26. http://dx.doi.org/10.1093/europace/eup068

Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009; 2: 16-24. http://dx.doi.org/10.1161/CIRCOUTCOMES.108.807123

Madotto F, Riva MA, Fornari C, Scalone L, Ciampichini R, Bonazzi C, et al. Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population. EBPH 2013; 10: 1-11.

Fellegi IP, Sunter AB. A theory for record linkage. J Am Stat Assoc 1969; 64: 1183-210. http://dx.doi.org/10.1080/01621459.1969.10501049

Newcombe HB. Handbook of Record Linkage: Methods for Health and Statistical Studies, Administration, and Business. Oxford University Press, Incorporated; 1988. http://dx.doi.org/10.1111/j.1553-2712.2006.tb00986.x

Fornari C, Madotto F, Demaria M, Romanelli A, Pepe P, Raciti M, et al. Record-linkage procedures in epidemiology: an Italian multicentre study. Epidemiol Prev 2008; 32: 79-88.

Newgard CD. Validation of probabilistic linkage to match deidentified ambulance records to a state trauma registry. Acad Emerg Med 2006; 13: 69-75.

OECD.STAT. I.Stat - The corporate statistical data warehouse. Italy: Istituto Nazionale di Statistica; 2014. http: //dati.istat.it/?lang=en. Accessed May 5, 2014

Thijssen J, Borleffs CJ, van Rees JB, Man S, de Bie MK, Venlet J, et al. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm 2012; 9: 513-9. http://dx.doi.org/10.1016/j.hrthm.2011.11.022

Horlbeck FW, Mellert F, Kreuz J, Nickenig G, Schwab JO. Real-world data on the lifespan of implantable cardioverterdefibrillators depending on manufacturers and the amount of ventricular pacing. J Cardiovasc Electrophysiol 2012; 23: 1336-42. http://dx.doi.org/10.1111/j.1540-8167.2012.02408.x

Shafat T, Baumfeld Y, Novack V, Konstantino Y, Amit G. Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs). Clin Res Cardiol 2013; 102: 43-9. http://dx.doi.org/10.1007/s00392-012-0493-6

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD- 9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-9. http://dx.doi.org/10.1097/01.mlr.0000182534.19832.83

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. http://dx.doi.org/10.1016/0021-9681(87)90171-8

Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-7. http://dx.doi.org/10.1016/j.jacc.2006.02.049

Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 2010; 170: 631-7. http://dx.doi.org/10.1001/archinternmed.2010.30

Bang H, Tsiatis AA. Estimating medical costs with censored data. Biometrika 2000; 87: 329-43. http://dx.doi.org/10.1093/biomet/87.2.329

Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P, et al. Impact of the main implantable cardioverterdefibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 2009; 11: 465-75. http://dx.doi.org/10.1093/europace/eun370

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50. http://dx.doi.org/10.1056/NEJMoa032423

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-8. http://dx.doi.org/10.1056/NEJMoa041489

Camm AJ, Nisam S. The utilization of the implantable defibrillator-a European enigma. Eur Heart J 2000; 21: 1998- 2004. http://dx.doi.org/10.1053/euhj.2000.2473

Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010; 33: 705-11. http://dx.doi.org/10.1111/j.1540-8159.2009.02670.x

Steinbrook R. The controversy over Guidant's implantable defibrillators. N Engl J Med 2005; 353: 221-4. http://dx.doi.org/10.1056/NEJMp058158

Diemberger I, Biffi M, Martignani C, Boriani G. From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems. Expert Review of Medical Devices 2011; 8: 235-55. http://dx.doi.org/10.1586/erd.10.80

Gandjour A, Holler A, Adarkwah CC. Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II). Value Health 2011; 14: 812- 7. http://dx.doi.org/10.1016/j.jval.2011.02.1180

Tuppin P, Neumann A, Marijon E, de Peretti C, Weill A, Ricordeau P, et al. Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008- 2009). Arch Cardiovasc Dis 2011; 104: 332-42. http://dx.doi.org/10.1016/j.acvd.2011.04.002

Sanders GD, Kong MH, Al-Khatib SM, Peterson ED. Costeffectiveness of implantable cardioverter defibrillators in patients ???? 65 years of age. Am Heart J 2010; 160: 122-31. http://dx.doi.org/10.1016/j.ahj.2010.04.021

Boriani G, Burri H, Mantovani LG, Maniadakis N, Leyva F, Kautzner J, et al. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace 2011; 13: ii59-ii65.

Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA-J Am Med Assoc 2013; 309: 55-62. http://dx.doi.org/10.1001/jama.2012.157182

Al-Khatib SM, Mi X, Wilkoff BL, Qualls LG, Frazier-Mills C, Setoguchi S, et al. Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice? Circ-Arrhythmia Elec 2013; 6: 108-16. http://dx.doi.org/10.1161/CIRCEP.112.974337

Downloads

Published

2022-06-15

How to Cite

Madotto, F., Fornari, C., Chiodini, V., Mantovani, L. G., Boriani, G., Conti, S., & Cesana, G. (2022). Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases. Global Journal Of Epidemiology and Public Health, 1(2), 48–56. https://doi.org/10.12974/2313-0946.2014.01.02.3

Issue

Section

Articles